Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 16 of 16 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Bioventus LLC | Activity: Research and Development | Company Description Bioventus develops and markets orthobiologic solutions for musculoskeletal healing and regeneration. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. | Location Durham |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company Charles River Laboratories (Durham) | Activity: Contract Research and Testing | Company Description Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services. | Location Durham |
| |
Company CytexOrtho | Activity: Research and Development | Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. | Location Durham |
| |
Company Doron Therapeutics | Activity: Research and Development | Company Description Doron Therapeutics is developing an injectable biologic to treat osteoarthritis and other musculoskeletal diseases. | Location Chapel Hill |
| |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham |
| |
Company MitoRainbow Therapeutics Inc. | Activity: Research and Development | Company Description MitoRainbow is developing treatments for TK2 deficiency, a mitochondrial disease that manifests as severe myopathy. | Location Cary |
| |
Company OsteoCure Therapeutics Inc. | Activity: Research and Development | Company Description OsteoCure Therapeutics develops novel treatments to accelerate and promote bone fracture healing and prevent nonunions. | Location Durham |
| |
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Durham |
| |
Company Reselute Inc. | Activity: Research and Development | Company Description Reselute is developing a medical device for the treatment of orthopedic implant related infections. | Location Durham |
| |
Company SP Innovations LLC | Activity: Research and Development | Company Description SP Innovations is developing a graft for irreparable rotator cuff tendon injuries. | Location Raleigh |
| |
Company Sparta Biomedical Inc. | Activity: Research and Development | Company Description Sparta Biomedical is developing cartilage-like implants to mimic the properties of native cartilage and address degeneration in joints. | Location Morrisville |
| |
Company Stryker | Activity: Production and Manufacturing | Company Description Stryker provides medical technology products with a focus in orthopaedics, neurotechnology and surgical devices. The Durham site developed and manufactures a surgical sealant device for use during cranial and spinal procedures. | Location Durham |
| |
Company UCB Biosciences Inc. | Activity: Research and Development | Company Description UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis. | Location Morrisville |